{
    "Trade/Device Name(s)": [
        "Alkaline Phosphatase2"
    ],
    "Submitter Information": "Abbott Ireland Diagnostics Division",
    "510(k) Number": "K223317",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023807"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJE"
    ],
    "Summary Letter Date": "June 15, 2023",
    "Summary Letter Received Date": "June 16, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1050"
    ],
    "Regulation Name(s)": [
        "Alkaline Phosphatase Or Isoenzymes Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alkaline phosphatase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Lithium heparin tube",
        "Lithium heparin separator tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c System"
    ],
    "Method(s)/Technology(ies)": [
        "Para-nitrophenyl phosphate (p-NPP) method",
        "Absorbance measurement at 404 nm"
    ],
    "Methodologies": [
        "Enzymatic colorimetric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Alkaline Phosphatase2 assay for quantitation of alkaline phosphatase in human serum or plasma on the ARCHITECT c System",
    "Indications for Use Summary": "Quantitation of alkaline phosphatase in human serum or plasma on the ARCHITECT c System as an aid in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases",
    "fda_folder": "Clinical Chemistry"
}